Viewing Study NCT06556004


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2026-02-23 @ 3:01 PM
Study NCT ID: NCT06556004
Status: UNKNOWN
Last Update Posted: 2024-08-15
First Post: 2024-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients
Sponsor: University of Chile
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma Stage IIIc View
None Melanoma Stage IV View
Keywords: